It sounded to me like Leo fully expects share price to rise from the acquisition because of the potential for Brilacidin. He mentioned the 250m market cap of the company acquired and that Cowan and Co. had an outperform rating on the stock. My question.......do you think Cowan would give a similar rating now to CTIX? It sure would be helpful . imo